150 related articles for article (PubMed ID: 17383583)
1. Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study.
Sorger D; Becker GA; Patt M; Schildan A; Grossmann U; Schliebs R; Seese A; Kendziorra K; Kluge M; Brust P; Mukhin AG; Sabri O
Nucl Med Biol; 2007 Apr; 34(3):331-42. PubMed ID: 17383583
[TBL] [Abstract][Full Text] [Related]
2. A simplified method for the measurement of nonmetabolized 2-[18F]F-A-85380 in blood plasma using solid-phase extraction.
Shumway DA; Pavlova OA; Mukhin AG
Nucl Med Biol; 2007 Feb; 34(2):221-8. PubMed ID: 17307130
[TBL] [Abstract][Full Text] [Related]
3. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
[TBL] [Abstract][Full Text] [Related]
4. Optimizing an online SPE-HPLC method for analysis of (R)-[11C]1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide [(R)-[11C]PK11195] and its metabolites in humans.
Greuter HN; van Ophemert PL; Luurtsema G; van Berckel BN; Franssen EJ; Windhorst BD; Lammertsma AA
Nucl Med Biol; 2005 Apr; 32(3):307-12. PubMed ID: 15820767
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and radiation dosimetry of 18F-fluoro-A-85380 in healthy volunteers.
Bottlaender M; Valette H; Roumenov D; Dollé F; Coulon C; Ottaviani M; Hinnen F; Ricard M
J Nucl Med; 2003 Apr; 44(4):596-601. PubMed ID: 12679405
[TBL] [Abstract][Full Text] [Related]
6. Binding properties of the cerebral alpha4beta2 nicotinic acetylcholine receptor ligand 2-[18F]fluoro-A-85380 to plasma proteins.
Sorger D; Becker GA; Hauber K; Schildan A; Patt M; Birkenmeier G; Otto A; Meyer P; Kluge M; Schliebs R; Sabri O
Nucl Med Biol; 2006 Oct; 33(7):899-906. PubMed ID: 17045170
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomography.
Vaupel DB; Tella SR; Huso DL; Wagner VO; Mukhin AG; Chefer SI; Horti AG; London ED; Koren AO; Kimes AS
J Pharmacol Exp Ther; 2005 Jan; 312(1):355-65. PubMed ID: 15331657
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of ethyl [(18)F]fluoroacetate as a proradiotracer of [(18)F]fluoroacetate for the measurement of glial metabolism by PET.
Mori T; Sun LQ; Kobayashi M; Kiyono Y; Okazawa H; Furukawa T; Kawashima H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2009 Feb; 36(2):155-62. PubMed ID: 19217527
[TBL] [Abstract][Full Text] [Related]
9. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies.
Obrzut SL; Koren AO; Mandelkern MA; Brody AL; Hoh CK; London ED
Nucl Med Biol; 2005 Nov; 32(8):869-74. PubMed ID: 16253812
[TBL] [Abstract][Full Text] [Related]
10. A restricted access material for rapid analysis of [(11)C]-labeled radiopharmaceuticals and their metabolites in plasma.
Gillings N
Nucl Med Biol; 2009 Nov; 36(8):961-5. PubMed ID: 19875053
[TBL] [Abstract][Full Text] [Related]
11. PET Imaging of nicotinic acetylcholine receptors in baboons with 18F-AZAN, a radioligand with improved brain kinetics.
Kuwabara H; Wong DF; Gao Y; Valentine H; Holt DP; Ravert HT; Dannals RF; Horti AG
J Nucl Med; 2012 Jan; 53(1):121-9. PubMed ID: 22173841
[TBL] [Abstract][Full Text] [Related]
12. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) in rodents and humans.
Bier D; Holschbach MH; Wutz W; Olsson RA; Coenen HH
Drug Metab Dispos; 2006 Apr; 34(4):570-6. PubMed ID: 16415116
[TBL] [Abstract][Full Text] [Related]
14. PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics.
Wong DF; Kuwabara H; Kim J; Brasic JR; Chamroonrat W; Gao Y; Valentine H; Willis W; Mathur A; McCaul ME; Wand G; Gean EG; Dannals RF; Horti AG
J Nucl Med; 2013 Aug; 54(8):1308-14. PubMed ID: 23801676
[TBL] [Abstract][Full Text] [Related]
15. Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.
Kendziorra K; Wolf H; Meyer PM; Barthel H; Hesse S; Becker GA; Luthardt J; Schildan A; Patt M; Sorger D; Seese A; Gertz HJ; Sabri O
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):515-25. PubMed ID: 21069319
[TBL] [Abstract][Full Text] [Related]
16. Graphical analysis of 2-[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain.
Chefer SI; London ED; Koren AO; Pavlova OA; Kurian V; Kimes AS; Horti AG; Mukhin AG
Synapse; 2003 Apr; 48(1):25-34. PubMed ID: 12557269
[TBL] [Abstract][Full Text] [Related]
17. Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [(18)F]FECT.
Chitneni SK; Garreau L; Cleynhens B; Evens N; Bex M; Vermaelen P; Chalon S; Busson R; Guilloteau D; Van Laere K; Verbruggen A; Bormans G
Nucl Med Biol; 2008 Jan; 35(1):75-82. PubMed ID: 18158946
[TBL] [Abstract][Full Text] [Related]
18. Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans.
Price JC; Lopresti BJ; Meltzer CC; Smith GS; Mason NS; Huang Y; Holt DP; Gunn RN; Mathis CA
Synapse; 2001 Jul; 41(1):11-21. PubMed ID: 11354009
[TBL] [Abstract][Full Text] [Related]
19. Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.
Kas A; Bottlaender M; Gallezot JD; Vidailhet M; Villafane G; Grégoire MC; Coulon C; Valette H; Dollé F; Ribeiro MJ; Hantraye P; Remy P
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1601-8. PubMed ID: 19491921
[TBL] [Abstract][Full Text] [Related]
20. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.
Gallezot JD; Bottlaender M; Grégoire MC; Roumenov D; Deverre JR; Coulon C; Ottaviani M; Dollé F; Syrota A; Valette H
J Nucl Med; 2005 Feb; 46(2):240-7. PubMed ID: 15695782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
